<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&amp;ev=PageView&amp;noscript=1">

Top 5 2012 Download

Download our 2012 Top 5
FDA Warning Letter Findings

2012 FDA Warning Letter Findings for Clinical Investigators

2012 FDA Warning Letter Findings for Clinical Investigators

After thorough review of the FDA warning letters issued to Clinical Investigators posted on FDA's website for 2012, we have once again compiled our list of the most frequent findings. This year, FDA issued only four warning letters to Clinical Investigators as a result of the Bioresearch Monitoring Inspectional program (BIMO). As a result, this year's list is actually IMARC's Top Five Warning Letter Findings for Clinical Investigators.